BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36045032)

  • 1. Effect of angiotensin II pathway inhibitors on post-surgical adhesion band formation: a potential repurposing of old drugs.
    Nazari SE; Naimi H; Sayyed-Hosseinian SH; Vahedi E; Daghiani M; Asgharzadeh F; Askarnia-Faal MM; Avan A; Khazaei M; Hassanian SM
    Injury; 2022 Nov; 53(11):3642-3649. PubMed ID: 36045032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposing of Angiotensin-converting-enzyme Inhibitor on Prevention of Post-surgical Tendon Adhesion.
    Naimi H; Khazaei M; Sharifnia F; Sayyed-Hosseinian SH
    Curr Pharm Des; 2024; 30(11):859-867. PubMed ID: 38468533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraperitoneal Administration of Telmisartan Prevents Postsurgical Adhesion Band Formation.
    Arjmand MH; Zahedi-Avval F; Barneh F; Mousavi SH; Asgharzadeh F; Hashemzehi M; Soleimani A; Avan A; Fakhraie M; Nasiri SN; Mehraban S; Ferns GA; Ryzhikov M; Jafari M; Khazaei M; Hassanian SM
    J Surg Res; 2020 Apr; 248():171-181. PubMed ID: 31923833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure. The replacement of angiotensin converting enzyme inhibition (REPLACE) investigators.
    Dunselman PH;
    Int J Cardiol; 2001 Feb; 77(2-3):131-8; discussion 139-40. PubMed ID: 11182175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of angiotensin-converting-enzyme inhibitors on the fibrous envelope around mammary implants.
    Zimman OA; Toblli J; Stella I; Ferder M; Ferder L; Inserra F
    Plast Reconstr Surg; 2007 Dec; 120(7):2025-2033. PubMed ID: 18090769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Therapeutic Potential of Targeting the Angiotensin Pathway as a Novel Therapeutic Approach to Ameliorating Post-surgical Adhesions.
    Khalili-Tanha G; Khalili-Tanha N; Nazari SE; Chaeichi-Tehrani N; Khazaei M; Aliakbarian M; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Avan A
    Curr Pharm Des; 2022; 28(3):180-186. PubMed ID: 34176457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hypertension with an angiotensin II-receptor antagonist compared with an angiotensin-converting enzyme inhibitor: a review of clinical studies of telmisartan and enalapril.
    Smith DH
    Clin Ther; 2002 Oct; 24(10):1484-501. PubMed ID: 12462282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of telmisartan and enalapril on renoprotection in patients with mild to moderate chronic kidney disease.
    Nakamura T; Fujiwara N; Kawagoe Y; Sugaya T; Ueda Y; Koide H
    Eur J Clin Invest; 2010 Sep; 40(9):790-6. PubMed ID: 20584070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective, randomized, single-blind comparison of effects of 6 months of treatment with telmisartan versus enalapril on high-molecular-weight adiponectin concentrations in patients with coronary artery disease.
    Satoh M; Tabuchi T; Minami Y; Takahashi Y; Itoh T; Nakamura M
    Clin Ther; 2009 Oct; 31(10):2113-25. PubMed ID: 19922882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of telmisartan on coronary stenting in patients with acute myocardial infarction compared with enalapril.
    Yokoyama J; Higuma T; Tomita H; Abe N; Oikawa K; Fujiwara T; Yokota T; Yokoyama H; Kimura M; Sasaki S; Hanada H; Osanai T; Okumura K
    Int J Cardiol; 2009 Feb; 132(1):114-20. PubMed ID: 18190989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of telmisartan on markers of ventricular remodeling in patients with acute myocardial infarction: comparison with enalapril.
    Yokota T; Osanai T; Hanada K; Kushibiki M; Abe N; Oikawa K; Tomita H; Higuma T; Yokoyama J; Hanada H; Okumura K
    Heart Vessels; 2010 Nov; 25(6):460-8. PubMed ID: 20922537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telmisartan ameliorates experimental autoimmune myocarditis associated with inhibition of inflammation and oxidative stress.
    Sukumaran V; Watanabe K; Veeraveedu PT; Ma M; Gurusamy N; Rajavel V; Suzuki K; Yamaguchi K; Kodama M; Aizawa Y
    Eur J Pharmacol; 2011 Feb; 652(1-3):126-35. PubMed ID: 21115000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of cardiac fibrosis by angiotensin II.
    Lijnen PJ; Petrov VV; Fagard RH
    Methods Find Exp Clin Pharmacol; 2000 Dec; 22(10):709-23. PubMed ID: 11346891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibition and angiotensin AT(1)-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity.
    Ibrahim MA; Ashour OM; Ibrahim YF; El-Bitar HI; Gomaa W; Abdel-Rahim SR
    Pharmacol Res; 2009 Nov; 60(5):373-81. PubMed ID: 19467331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.
    Barnett AH; Bain SC; Bouter P; Karlberg B; Madsbad S; Jervell J; Mustonen J;
    N Engl J Med; 2004 Nov; 351(19):1952-61. PubMed ID: 15516696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. TEES Study Group.
    Karlberg BE; Lins LE; Hermansson K
    J Hypertens; 1999 Feb; 17(2):293-302. PubMed ID: 10067800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telmisartan versus angiotension-converting enzyme inhibitors in the treatment of hypertension: a meta-analysis of randomized controlled trials.
    Zou Z; Xi GL; Yuan HB; Zhu QF; Shi XY
    J Hum Hypertens; 2009 May; 23(5):339-49. PubMed ID: 18987649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing renal complications in type 2 diabetes: results of the diabetics exposed to telmisartan and enalapril trial.
    Barnett A
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S132-5. PubMed ID: 16565237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of telmisartan compared to enalapril in patients with severe hypertension.
    Neutel JM; Smith DH; Reilly PA
    Int J Clin Pract; 1999; 53(3):175-8. PubMed ID: 10665127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of telmisartan in the treatment of hypertension.
    White WB
    J Clin Hypertens (Greenwich); 2002; 4(4 Suppl 1):20-5. PubMed ID: 12147925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.